Little, Mark W. http://orcid.org/0000-0002-5003-1070
Harrison, Richard
MacGill, Sarah
Speirs, Archie
Briggs, James H.
Tayton, Edward
Davies, Nev L. C.
Hausen, Heike S.
McCann, Claire
Levine, Lisa L.
Sharma, Ricky A.
Gibson, Matthew
Clinical trials referenced in this document:
Documents that mention this clinical trial
Genicular Artery Embolisation in Patients with Osteoarthritis of the Knee (GENESIS 2): Protocol for a Double-Blind Randomised Sham-Controlled Trial
https://doi.org/10.1007/s00270-023-03477-z
Funding for this research was provided by:
Varian Medical Systems
Article History
Received: 30 March 2023
Accepted: 23 May 2023
First Online: 19 June 2023
Declarations
:
: MWL, the Chief/Principal Investigator of the Genesis II study: is a paid consultant for Merit Medical, Crannmed, Boston Scientific, and Guerbet; has received support to attend meetings from Merit Medical and Guerbet; and is a member of the CIRSE Next Research Advisory Board. RH has received honorarium from Crannmed. JB has received payment for delivering educational webinars from Merit Medical and is a member of the safety and quality board in the British Society of Interventional Radiology. HH, CM, LL, and RS are employees of Varian Medical Systems, a Siemens Healthineers Company, and CM, LL, and RS have stock or stock options in the company. The other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants will be in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent will be obtained from all individual participants included in the study.
: Consent for publication will be obtained for every individual person’s data included in the study.